Oreshkova, N.; Myeni, S.K.; Mishra, N.; Albulescu, I.C.; Dalebout, T.J.; Snijder, E.J.; Bredenbeek, P.J.; Dallmeier, K.; Kikkert, M.
A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses. Vaccines 2021, 9, 1492.
https://doi.org/10.3390/vaccines9121492
AMA Style
Oreshkova N, Myeni SK, Mishra N, Albulescu IC, Dalebout TJ, Snijder EJ, Bredenbeek PJ, Dallmeier K, Kikkert M.
A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses. Vaccines. 2021; 9(12):1492.
https://doi.org/10.3390/vaccines9121492
Chicago/Turabian Style
Oreshkova, Nadia, Sebenzile K. Myeni, Niraj Mishra, Irina C. Albulescu, Tim J. Dalebout, Eric J. Snijder, Peter J. Bredenbeek, Kai Dallmeier, and Marjolein Kikkert.
2021. "A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses" Vaccines 9, no. 12: 1492.
https://doi.org/10.3390/vaccines9121492
APA Style
Oreshkova, N., Myeni, S. K., Mishra, N., Albulescu, I. C., Dalebout, T. J., Snijder, E. J., Bredenbeek, P. J., Dallmeier, K., & Kikkert, M.
(2021). A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses. Vaccines, 9(12), 1492.
https://doi.org/10.3390/vaccines9121492